Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Novo Nordisk A/S: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

30 Apr 2016 Reuters Investment Profile 12 $20.00

Novo Nordisk A/S: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

20 May 2016 Reuters Investment Profile 12 $20.00

ValuEngine Rating and Forecast Report for NVO

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

22 May 2016 ValuEngine, Inc. 11 $25.00

NOVO NORDISK AS (NVO=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

21 May 2016 Pechala's Reports 2 $25.00

Validea Guru Analysis Report for NVO. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.

Validea's Guru Stock Report uses an interpretation of the published stock-picking strategies developed by 10 investing legend...

20 May 2016 Validea 0 $12.00

Value Graph: NOVO-NORDISK -- NVO

20 May 2016 Ford Investor Services, Inc. 1 $12.00

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of NOVO-NORDISK A/S -ADR including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

20 May 2016 Jefferson Research 11 $20.00

Company Snapshot - Novo Nordisk AS

A director at Novo Nordisk AS bought 1,200 shares at 359.062DKK and the significance rating of the trade was 55/100. Is that...

04 May 2016 Directors Deals Ltd. 1 $12.00

Novo Nordisk A/S (NOVO B) - Financial and Strategic SWOT Analysis Review

Novo Nordisk A/S (NOVO B) - Financial and Strategic SWOT Analysis Review Summary Novo Nordisk A/S (Novo Nordisk) is a healthc...

03 May 2016 GlobalData 195 $300.00

NOVOb.CO - Event Brief of Novo Nordisk A/S conference call, May 03, 2016 / 8:15AM ET

Edited Event Brief of NOVOb.CO conference call, May 03, 2016 / 8:15AM ET London, May 5, 2016 (Thomson StreetEvents) Q1...

03 May 2016 Thomson Reuters StreetEvents 18 $75.00